Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
OGN is expected to report earnings to 90 cents per share on May 01
Q1'25
Est.
$0.91
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.24
The last earnings report on February 13 showed earnings per share of 89 cents, missing the estimate of 91 cents. With 266.10K shares outstanding, the current market capitalization sits at 4.73B.